Medicare is willing to reevaluate its coverage of Alzheimer’s drugs in light of a new therapy, called lecanemab, that has shown potentially more promising
Tag - Medicare
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow of money through the health care system. Sign up here to get it
The Department of Justice filed a new lawsuit against Cigna Monday, alleging the health insurance company overcharged the federal government by purposefully
Modern wheelchairs have amazing capabilities. At the push of a button, they can position a user in a “standing” position, or elevate someone to eye level with
Medicare is vastly underserving older Americans with opioid use disorder, with only 18% of enrollees with the diagnosis receiving recommended medication
Both of us have spent much of our lives in wheelchairs. But not just any wheelchairs. Ours are equipped with power seat elevation and standing technologies
Casinos dazzle you with flashing lights, high-stakes tables, and the chance to win millions of dollars. The house always wins, but casinos still trick people
The Centers for Medicare and Medicaid Services (CMS) issued on Thursday its hotly debated final decision on whether to cover aducanumab (Aduhelm), the first
In a clash of two American health care giants, the Centers for Medicare and Medicaid Services (CMS) and the Food and Drug Administration (FDA) had locked horns
WASHINGTON — Medicare on Thursday finalized its plan to restrict coverage for the controversial, pricey Alzheimer’s drug Aduhelm to patients participating in
